PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Jargosch, M. ; Kuruvila, J.* ; Scala, E.* ; Grosch, J. ; Eigemann, J. ; Wasserer, S. ; Lekiashvili, S.* ; Trautwein, N.* ; Kowalewski, D.J.* ; Böhner, A.* ; Köseoglu, Y. ; Hillig, C. ; Thomas, J. ; Lauffer, F. ; Schmidt-Weber, C.B. ; Menden, M.P. ; Walz, J.S.* ; Kaesler, S.* ; Eyerich, S. ; Blank, S. ; Rammensee, H.G.* ; Biedermann, T.* ; Eyerich, K.* ; Kurgyis, Z.* ; Freudenmann, L.K.* ; Garzorz-Stark, N.*

Immunopeptidome analysis reveals SERPINB3 as an autoantigen driving eczematized psoriasis.

Sci. Adv. 11, 16:eadx0637 (2025)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Psoriasis (Pso) is a chronic inflammatory skin disease driven by T helper 17 (TH17) cells, with several clinical subtypes. While self-reactive immune responses have been observed, the role of autoantigens in Pso remains unclear. Using immunopeptidomics, we identified serpin family B member 3 (SERPINB3) and SERPINB4 as candidate autoantigens in Pso skin. In a mouse model, the SERPINB3 ortholog Serpinb3b enhanced inflammation, promoted tissue-resident memory T cells, and skewed immunity toward a TH2 phenotype. In humans, SERPINB3 reactivity was specifically associated with "eczematized psoriasis" (EczPso), a subtype marked by TH2/TH17 immune signatures. SERPINB3 protein was enriched in EczPso lesions and highly secreted by keratinocytes under combined TH2/TH17 stimulation. Lesional T cells from EczPso-but not from eczema or classical plaque Pso-proliferated in response to SERPINB3 and induced EczPso-like features in a skin model. Our findings identify SERPINB3 as an autoantigen driving a distinct Pso subtype, supporting more precise diagnosis and therapy.
Impact Factor
Scopus SNIP
Altmetric
12.500
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter T-cells; Monoclonal-antibodies; Skin Inflammation; Atopic-dermatitis; Dendritic Cells; Pso P27; Hla; Peptides; Antigens; Protein
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 2375-2548
e-ISSN 2375-2548
Zeitschrift Science Advances
Quellenangaben Band: 11, Heft: 43, Seiten: 16, Artikelnummer: eadx0637 Supplement: ,
Verlag American Association for the Advancement of Science (AAAS)
Verlagsort Washington, DC [u.a.]
Begutachtungsstatus Peer reviewed
Institut(e) Institute for Allergy Research (IAF)
Institute of Computational Biology (ICB)
POF Topic(s) 30202 - Environmental Health
30205 - Bioengineering and Digital Health
Forschungsfeld(er) Allergy
Enabling and Novel Technologies
PSP-Element(e) G-505490-001
G-505400-001
G-554700-001
Förderungen
German Research Foundation (DFG)
GSC 81 "international Graduate School of Science and Engineering (iGSSE)
DOI 10.1126/sciadv.adx0637
WOS ID 001598753100033
Scopus ID 105019727952
PubMed ID 41124250
Erfassungsdatum 2025-10-23
[➜Korrektur melden]